Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 4,283 Cr.
- Current Price ₹ 154
- High / Low ₹ 241 / 107
- Stock P/E 54.0
- Book Value ₹ 71.6
- Dividend Yield 0.32 %
- ROCE 4.69 %
- ROE 4.08 %
- Face Value ₹ 2.00
Pros
Cons
- The company has delivered a poor sales growth of 9.99% over past five years.
- Tax rate seems low
- Company has a low return on equity of 5.67% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 8.64% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.15%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,797 | 2,865 | 2,985 | 2,847 | |
| 988 | 966 | 957 | 1,222 | 1,414 | 1,418 | 1,548 | 2,713 | 2,548 | 2,609 | 2,699 | 2,675 | |
| Operating Profit | 86 | 80 | 119 | 154 | 155 | 117 | 220 | 371 | 248 | 256 | 286 | 171 |
| OPM % | 8% | 8% | 11% | 11% | 10% | 8% | 12% | 12% | 9% | 9% | 10% | 6% |
| 1 | 2 | 2 | 3 | 6 | 30 | 4 | 15 | 12 | 28 | 19 | 15 | |
| Interest | 26 | 19 | 11 | 12 | 19 | 17 | 19 | 19 | 15 | 7 | 20 | 22 |
| Depreciation | 30 | 29 | 28 | 31 | 44 | 49 | 47 | 49 | 72 | 107 | 124 | 77 |
| Profit before tax | 31 | 34 | 82 | 113 | 98 | 81 | 158 | 318 | 173 | 171 | 161 | 88 |
| Tax % | 31% | 22% | 13% | 33% | 26% | 13% | 20% | 19% | 28% | 29% | 29% | 10% |
| 21 | 27 | 72 | 76 | 72 | 70 | 127 | 256 | 125 | 121 | 114 | 79 | |
| EPS in Rs | 21.12 | 26.56 | 71.50 | 75.63 | 14.46 | 15.57 | 4.82 | 9.72 | 4.70 | 4.37 | 4.10 | 2.86 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 11% | 10% | 7% | 11% | 14% | 12% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 1% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | -9% |
| 3 Years: | -14% |
| TTM: | -28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -7% |
| 3 Years: | -15% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 | 55 |
| Reserves | 199 | 225 | 295 | 369 | 400 | 382 | 982 | 1,248 | 1,359 | 1,742 | 1,851 | 1,930 |
| 249 | 221 | 104 | 215 | 175 | 159 | 149 | 139 | 406 | 143 | 258 | 543 | |
| 152 | 176 | 240 | 300 | 389 | 484 | 654 | 825 | 595 | 887 | 880 | 917 | |
| Total Liabilities | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,265 | 2,412 | 2,827 | 3,045 | 3,446 |
| 226 | 215 | 202 | 293 | 346 | 338 | 325 | 394 | 715 | 879 | 1,166 | 1,481 | |
| CWIP | 25 | 40 | 61 | 30 | 31 | 67 | 148 | 374 | 447 | 444 | 398 | 652 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 23 | 126 | 148 | 37 |
| 358 | 377 | 386 | 571 | 637 | 664 | 1,361 | 1,492 | 1,228 | 1,378 | 1,332 | 1,276 | |
| Total Assets | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,265 | 2,412 | 2,827 | 3,045 | 3,446 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80 | 150 | -7 | 188 | 196 | 106 | 46 | 199 | 561 | 108 | 175 | ||
| -21 | -37 | -85 | -123 | -56 | -641 | 95 | -384 | -490 | -268 | -404 | ||
| -57 | -107 | 85 | -63 | -123 | 527 | -124 | 232 | -42 | 90 | 247 | ||
| Net Cash Flow | 1 | 6 | -7 | 2 | 16 | -7 | 16 | 47 | 30 | -70 | 18 | |
| Free Cash Flow | 53 | 114 | -95 | 90 | 118 | -10 | -243 | -277 | 314 | -286 | -427 | |
| CFO/OP | 90% | 113% | 13% | 139% | 181% | 60% | 27% | 100% | 234% | 47% | 108% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 67 | 79 | 86 | 76 | 86 | 90 | 79 | 74 | 74 | 66 | 67 |
| Inventory Days | 37 | 57 | 37 | 55 | 57 | 51 | 63 | 65 | 58 | 54 | 71 | 70 |
| Days Payable | 52 | 67 | 85 | 81 | 105 | 138 | 148 | 123 | 92 | 145 | 131 | 140 |
| Cash Conversion Cycle | 49 | 56 | 30 | 60 | 28 | -1 | 5 | 21 | 41 | -16 | 6 | -3 |
| Working Capital Days | 65 | 66 | 36 | 28 | 28 | 17 | -1 | 42 | 31 | 19 | 12 | 35 |
| ROCE % | 12% | 22% | 25% | 19% | 12% | 20% | 26% | 11% | 9% | 9% | 5% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Installed Capacity - Ethyl Acetate MTPA |
|
|||||||
| Domestic Market Share - Diketene Derivatives (Specialties) % |
||||||||
| Domestic Market Share - Ethyl Acetate (Essentials) % |
||||||||
| Specific Steam Consumption (Ethyl Acetate) MT/MT |
||||||||
| Specific Electrical Energy Consumption (Ethyl Acetate) kw/MT |
||||||||
| Installed Capacity - Fluorospecialty (Lote Site) MTPA |
||||||||
| Number of Active Customers Count |
||||||||
| Number of Diketene Derivative Products Count |
||||||||
| Revenue Contribution from New Products (launched in last 5 years) % |
||||||||
| Total Volume Growth (Group) % |
||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Laxmi Organic Industries Limited has Submitted copy of Newspaper Publication of the Financial Results for the Fourth Quarter and Year ended March 31, 2026.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
22 May - Ethyl Acetate Plant commissioned at Lote Site; commercial dispatches commenced on May 22, 2026.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
22 May - Monitoring agency report for quarter ended 31 March 2026 confirms no deviation in QIP proceeds.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22 May - Company shared recording of investor and analyst meet for Q4 and FY2026 results.
-
Announcement Under Regulation 30 Regarding Clarification/Correction In The Consolidated Financial Results For The Quarter And Year Ended March 31, 2026.
21 May - Board approved FY26 audited results, 30 paise final dividend, AGM on Aug 5, and CFO Amit Jain appointment.
Annual reports
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
May 2025TranscriptAI SummaryPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptAI SummaryPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptAI SummaryPPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.